© 2022 MJH Life Sciences™ and Contemporary OB/GYN. All rights reserved.
Obstetrics
Study examines best practices for managing perinatal depression
May 16, 2022
Recommendations are often vague, contradictory, according to investigators.
Deep dive into hypertensive disorders in pregnancy
May 16, 2022
Diagnosis, management imperative for gestational hypertension and preeclampsia.
Maternal immunization with investigational RSV vaccine conferred protection to infants
May 12, 2022
Active immunization of pregnant women with investigational vaccine protected infants from RSV from birth through at least 6 months.
Self-monitoring BP did not improve control for pregnant patients with hypertension
May 10, 2022
There was no statistically significant difference in mean systolic blood pressure for the self-monitoring groups vs the usual care group.
Psychological reflections on miscarriage
May 10, 2022
When helping patients in the hardest moments of their lives, it is important to have empathy for them—and for ourselves.
Strategies to improve DEI in obstetrics and gynecology
May 06, 2022
Catherine Cansino, MD; Andrea Braden, MD; and Lisa Foglia, MD, spoke on how Metrics, wellness models, and management change are essential to advancing diversity, equity, and inclusion (DEI) in obstetrics and gynecology at the 2022 ACOG Annual Clinical & Scientific Meeting.
Making obstetrics and gynecology a more diverse and equitable environment
May 06, 2022
In this EdTalk, presented at the 2022 American College of Obstetricians & Gynecologists' Annual Clinical & Scientific Meeting, Lisa Foglia, MD; Andrea L. Braden, MD; and Catherine Cansino, MD, MPH, discuss strategies for improving diversity and equity within obstetrics and gynecology.
FDA warn public of risks, false results with noninvasive prenatal screening tests
April 27, 2022
The FDA recently issued a statement warning the public of the risks and potential false results obtained with noninvasive prenatal screening tests, noting that inappropriate usage and interpretation has resulted in improper medical decisions.
Labor neuraxial analgesia and maternal morbidity
April 21, 2022
The use of labor neuraxial analgesia for vaginal delivery was associated with a 14% decrease in the risk of severe maternal morbidity (SMM), including postpartum hemorrhage (PPH), compared to vaginal delivery without neuraxial analgesia, according to a study published in JAMA Network Open.
SARS-CoV-2 infections and serious obstetric complications
April 20, 2022
A retrospective cohort study published in JAMA found that pregnant and postpartum women with SARS-CoV-2 infection were at a significantly increased risk of maternal mortality or serious morbidity from common obstetric complications.